Clinical Trial Update: Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy [Phase 3]

View source ↗

Summary

Phase 3 study results evaluate the efficacy and safety of short ragweed pollen sublingual immunotherapy for ragweed allergy. Results have been posted after the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Short Ragweed Pollen Sublingual Immunotherapy

Snippet

Sponsor: Greer Laboratories | Conditions: Allergy | Phase 3 | Status: COMPLETED | Results posted: 2015-02-05